drugset / Trial / NCT00987662

Irbesartan Versus Amlodipine: The OBI Study

NCT00987662

RandomizedParallel-groupOpen-labelDiagnostic

Summary

Objective: 1. To study the effectiveness of irbesartan 300mg and amlodipine 10 mg in 24h ambulatory blood pressure values in obese subjects 2. To study the drug specific effect in arterial stiffness 3. To study possible drug mechanisms in obesity (reduction of central adiposity and changing the ratio of leptin to adiponectin)

Timeline

Start
2012-01
Primary completion
2013-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 10 mg
Comparator Irbesartan Small molecule 300 mg
Comparator Hydrochlorothiazide Unknown 12.5 mg